<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<headerData>
<submissionType>144</submissionType>
<filerInfo>
<filer>
<filerCredentials>
<cik>0001773187</cik>
<ccc>XXXXXXXX</ccc>
</filerCredentials>
</filer>
<liveTestFlag>LIVE</liveTestFlag>
</filerInfo>
</headerData>
<formData>
<issuerInfo>
<issuerCik>0001861560</issuerCik>
<issuerName>Nuvalent, Inc.</issuerName>
<secFileNumber>001-40671</secFileNumber>
<issuerAddress>
<street1 xmlns="http://www.sec.gov/edgar/common">One Broadway</street1>
<street2 xmlns="http://www.sec.gov/edgar/common">14th Floor</street2>
<city xmlns="http://www.sec.gov/edgar/common">Cambridge</city>
<stateOrCountry xmlns="http://www.sec.gov/edgar/common">MA</stateOrCountry>
<zipCode xmlns="http://www.sec.gov/edgar/common">02142</zipCode>
</issuerAddress>
<issuerContactPhone>857-357-7000</issuerContactPhone>
<nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>Bain Capital Life Sciences Fund II, L.P.</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
<relationshipsToIssuer>
<relationshipToIssuer>Affiliate</relationshipToIssuer>
</relationshipsToIssuer>
</issuerInfo>
<securitiesInformation>
<securitiesClassTitle>Class A Common Stock</securitiesClassTitle>
<brokerOrMarketmakerDetails>
<name>Goldman Sachs &amp; Co. LLC</name>
<address>
<street1 xmlns="http://www.sec.gov/edgar/common">200 West Street</street1>
<city xmlns="http://www.sec.gov/edgar/common">New York</city>
<stateOrCountry xmlns="http://www.sec.gov/edgar/common">NY</stateOrCountry>
<zipCode xmlns="http://www.sec.gov/edgar/common">10282</zipCode>
</address>
</brokerOrMarketmakerDetails>
<noOfUnitsSold>1114286</noOfUnitsSold>
<aggregateMarketValue>104308312</aggregateMarketValue>
<noOfUnitsOutstanding>65617305</noOfUnitsOutstanding>
<approxSaleDate>12/11/2024</approxSaleDate>
<securitiesExchangeName>NASDAQ</securitiesExchangeName>
</securitiesInformation>
<securitiesToBeSold>
<securitiesClassTitle>Class A Common Stock</securitiesClassTitle>
<acquiredDate>04/30/2021</acquiredDate>
<natureOfAcquisitionTransaction>Purchase of preferred stock from the Issuer, which was automatically converted into shares of Class A Common Stock immediately prior to the closing of the Issuer's initial public offering</natureOfAcquisitionTransaction>
<nameOfPersonfromWhomAcquired>Issuer</nameOfPersonfromWhomAcquired>
<isGiftTransaction>N</isGiftTransaction>
<amountOfSecuritiesAcquired>2400630</amountOfSecuritiesAcquired>
<paymentDate>04/30/2021</paymentDate>
<natureOfPayment>Cash</natureOfPayment>
</securitiesToBeSold>
<nothingToReportFlagOnSecuritiesSoldInPast3Months>Y</nothingToReportFlagOnSecuritiesSoldInPast3Months>
<noticeSignature>
<noticeDate>12/11/2024</noticeDate>
<signature>/s/ Andrew Hack, as Partner of Bain Capital Life Sciences Investors, LLC</signature>
</noticeSignature>
</formData>
</edgarSubmission>
